- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- monomer
- Ligands
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x EN5: N-(10-AMINODECANOYL)-L-SERYL-N-(2-CYCLOHEXYLETHYL)-L-LYSINAMIDE(Non-covalent)
- 1 x COA: COENZYME A(Non-covalent)
COA.3: 23 residues within 4Å:- Chain A: H.2, A.3, F.4, W.5, N.69, Y.70, V.71, L.159, C.160, V.161, R.166, E.167, K.168, R.169, L.170, A.171, P.172, T.193, L.198
- Ligands: MG.1, EN5.2, MYA.4, ENF.5
22 PLIP interactions:22 interactions with chain A- Hydrophobic interactions: A:Y.70, A:V.71, A:L.159, A:V.161
- Hydrogen bonds: A:A.3, A:F.4, A:W.5, A:L.159, A:V.161, A:R.166, A:E.167, A:R.169, A:L.170, A:A.171
- Water bridges: A:H.2, A:E.167, A:R.169, A:R.169, A:R.169
- Salt bridges: A:H.2, A:R.169, A:R.169
- 1 x MYA: TETRADECANOYL-COA(Non-covalent)
MYA.4: 34 residues within 4Å:- Chain A: H.2, A.3, F.4, W.5, N.69, Y.70, V.71, I.156, N.157, F.158, L.159, C.160, V.161, R.166, E.167, K.168, R.169, L.170, A.171, P.172, T.179, V.182, N.183, W.188, Q.189, A.190, Y.192, T.193, L.198, Y.394
- Ligands: MG.1, EN5.2, COA.3, ENF.5
38 PLIP interactions:38 interactions with chain A- Hydrophobic interactions: A:W.5, A:Y.70, A:V.71, A:I.156, A:I.156, A:L.159, A:L.159, A:L.159, A:V.161, A:V.182, A:A.190, A:Y.192, A:Y.192, A:Y.394, A:Y.394
- Hydrogen bonds: A:A.3, A:F.4, A:W.5, A:Y.70, A:F.158, A:L.159, A:L.159, A:V.161, A:R.166, A:R.166, A:E.167, A:R.169, A:L.170, A:A.171
- Water bridges: A:H.2, A:H.2, A:E.167, A:R.169, A:R.169, A:R.169
- Salt bridges: A:H.2, A:R.169, A:R.169
- 1 x ENF: N-{(5E)-10-[(9E)-TETRADEC-9-ENOYLAMINO]DEC-5-ENOYL}-L-SERYL-N-(2-CYCLOHEXYLETHYL)-L-LYSINAMIDE(Non-covalent)
ENF.5: 38 residues within 4Å:- Chain A: W.5, Y.70, V.71, D.73, D.74, D.75, M.77, F.78, I.156, N.157, F.158, L.159, T.179, V.182, N.183, W.188, Q.189, A.190, Y.192, T.193, G.195, Y.207, H.209, S.211, F.222, S.223, Y.243, G.383, A.384, G.385, D.386, G.387, L.389, Y.394
- Ligands: EN5.2, COA.3, MYA.4, DMS.7
26 PLIP interactions:26 interactions with chain A- Hydrophobic interactions: A:W.5, A:V.71, A:F.78, A:I.156, A:L.159, A:L.159, A:V.182, A:A.190, A:Y.192, A:Y.192, A:Y.207, A:F.222, A:F.222, A:Y.394
- Hydrogen bonds: A:Y.70, A:Y.70, A:D.75, A:F.158, A:L.159, A:T.193, A:F.222, A:D.386, A:D.386, A:G.387
- Water bridges: A:D.74, A:T.193
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
DMS.6: 8 residues within 4Å:- Chain A: F.80, Y.82, Y.207, Y.316, I.318, Y.335, M.410, L.411
1 PLIP interactions:1 interactions with chain A- Water bridges: A:Y.335
DMS.7: 5 residues within 4Å:- Chain A: F.78, F.80, S.320
- Ligands: EN5.2, ENF.5
1 PLIP interactions:1 interactions with chain A- Hydrogen bonds: A:S.320
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Olaleye, T.O. et al., Peptidomimetic Inhibitors of N-Myristoyltransferase from Human Malaria and Leishmaniasis Parasites. Org.Biomol.Chem. (2014)
- Release Date
- 2014-09-24
- Peptides
- GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.40 Å
- Oligo State
- monomer
- Ligands
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x EN5: N-(10-AMINODECANOYL)-L-SERYL-N-(2-CYCLOHEXYLETHYL)-L-LYSINAMIDE(Non-covalent)
- 1 x COA: COENZYME A(Non-covalent)
- 1 x MYA: TETRADECANOYL-COA(Non-covalent)
- 1 x ENF: N-{(5E)-10-[(9E)-TETRADEC-9-ENOYLAMINO]DEC-5-ENOYL}-L-SERYL-N-(2-CYCLOHEXYLETHYL)-L-LYSINAMIDE(Non-covalent)
- 2 x DMS: DIMETHYL SULFOXIDE(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Olaleye, T.O. et al., Peptidomimetic Inhibitors of N-Myristoyltransferase from Human Malaria and Leishmaniasis Parasites. Org.Biomol.Chem. (2014)
- Release Date
- 2014-09-24
- Peptides
- GLYCYLPEPTIDE N-TETRADECANOYLTRANSFERASE: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
A